Compare Reddit Inc (RDDT) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Reddit Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Reddit Inc trades at $170.64 (market cap $35.78B), while Regeneron Pharmaceuticals Inc trades at $653.5 (market cap $70.79B). The key difference: Regeneron Pharmaceuticals Inc is the larger of the two by market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while Reddit Inc pays none. Which is the better fit depends on your goals.
| RDDT | REGN | |
|---|---|---|
Market Cap | $35.78B | $70.79B |
Sector | Media | Health |
52-Week High | $270.71 | $812.27 |
52-Week Low | $121.84 | $545.46 |
Enterprise Value | $33.03B | $64.74B |
Dividend Yield | — | 0.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Reddit (RDDT) trades at $181.67, up 0.21% today, with a bearish technical signal but strong fundamentals including 91.37% gross margins and recent earnings beats. Analyst consensus is bullish with a $236.89 price target, and institutional interest is rising, as seen with Andra AP fonden's 152.6% stake increase in Q1 2026 (SEC filing, July 21, 2026).
The outlook is positive due to robust revenue growth and AI initiatives, but risks include high valuation multiples and competitive pressures. Near-term focus is on Q2 2026 earnings due July 30, 2026, which could drive volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
